Offering safe affordable family-forming programs for everyone, including vulnerable or under-served employee populations, represents an opportunity for employers to build a caring culture that also will benefit the bottom line.
CB Insights released a list of what it deems to be the 50 most promising digital health companies of 2023. The market research firm said that the startups on the list are working to improve four main aspects of healthcare: personalization, efficiency, equity and accessibility.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
President Joe Biden's pick for CMS administrator, Chiquita Brooks-LaSure, is slated to become the first Black woman to hold the post. Her policy priorities will likely center on healthcare access, including expanding insurance coverage, and health equity.
Roughly a third of adults had a telehealth visit in the first 6 months of the pandemic, according to a new survey conducted by the Urban Institute. But not everyone who wanted a telehealth visit was able to access it, leaving some adults with unmet care needs.
The insurance startup led by UnitedHealthcare’s former CEO closed a $635 million funding round led by New Enterprise Associates.
Sarepta Therapeutics gains rights to University of Florida-resident startup's programs for central nervous system diseases.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The company plans to use the funding to advance clinical candidates and expand its portfolio, which touches a wide range of diseases.
Right on the heels of embarking on two new Phase 1 trials, epigenetics player Constellation Pharma has raised $5 million in an internal round from existing investors – a solid chunk of change. “It’s just the amount we needed to top off our balance sheet in order to take the company to a decision point for […]